se ha leído el artículo
array:23 [ "pii" => "S1578219017301853" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.04.003" "estado" => "S300" "fechaPublicacion" => "2017-09-01" "aid" => "1678" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2017" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2017;108:606" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 615 "formatos" => array:3 [ "EPUB" => 37 "HTML" => 420 "PDF" => 158 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731017302107" "issn" => "00017310" "doi" => "10.1016/j.ad.2017.04.008" "estado" => "S300" "fechaPublicacion" => "2017-09-01" "aid" => "1678" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2017;108:606" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 474 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 343 "PDF" => 129 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Ivermectina oral: recuperando un fármaco para el tratamiento de la escabiosis" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "606" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Oral Ivermectin: Regaining a Drug for the Treatment of Scabies" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "G. Blasco Morente" "autores" => array:1 [ 0 => array:2 [ "nombre" => "G." "apellidos" => "Blasco Morente" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219017301853" "doi" => "10.1016/j.adengl.2017.04.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301853?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302107?idApp=UINPBA000044" "url" => "/00017310/0000010800000007/v2_201708291352/S0001731017302107/v2_201708291352/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219017301865" "issn" => "15782190" "doi" => "10.1016/j.adengl.2017.04.004" "estado" => "S300" "fechaPublicacion" => "2017-09-01" "aid" => "1679" "copyright" => "Elsevier España, S.L.U. and AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2017;108:607" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 559 "formatos" => array:3 [ "EPUB" => 38 "HTML" => 413 "PDF" => 108 ] ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentary</span>" "titulo" => "Variability in Therapeutic Decision Making: Evaluation of the Validity of an Information and Communication Technology Tool" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "607" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Variabilidad en la toma de decisiones terapéuticas. A propósito de la evaluación de la fiabilidad de una herramienta TIC" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "F. Rivas Ruiz" "autores" => array:1 [ 0 => array:2 [ "nombre" => "F." "apellidos" => "Rivas Ruiz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731017302119" "doi" => "10.1016/j.ad.2017.04.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302119?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301865?idApp=UINPBA000044" "url" => "/15782190/0000010800000007/v2_201708291348/S1578219017301865/v2_201708291348/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentary</span>" "titulo" => "Oral Ivermectin: Regaining a Drug for the Treatment of Scabies" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "606" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "G. Blasco Morente" "autores" => array:1 [ 0 => array:3 [ "nombre" => "G." "apellidos" => "Blasco Morente" "email" => array:1 [ 0 => "gonzaloblascomorente@gmail.com" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Facultativo Especialista de Dermatología Médico Quirúrgica y Venereología, Hospital de Alta Resolución de Alcalá la Real, Alcalá la Real, Jaén, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ivermectina oral: recuperando un fármaco para el tratamiento de la escabiosis" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The article by our colleagues at Hospital Rey Juan Carlos and Hospital La Princesa reminds us of the possibility of using oral ivermectin to treat scabies.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> This treatment is accepted, recognized, and widely used in other countries—for example, Brazil—but a commercial formulation is not available in Spain. Therefore, the use of this treatment is limited and it must be specially prepared or requested for use as a foreign medication.</p><p id="par0010" class="elsevierStylePara elsevierViewall">This medication is usually administered as a single 200<span class="elsevierStyleHsp" style=""></span>μg/kg dose. However, this study found that a high percentage of patients required 2 or 3 doses. The authors therefore decided to increase the single dose to 400<span class="elsevierStyleHsp" style=""></span>μg/kg and found that the medication was well tolerated. The 13 patients treated at this dosage were cured and did not require a second dose.</p><p id="par0015" class="elsevierStylePara elsevierViewall">At both dosages, nearly half of the patients had eczematous eruptions as a side effect and required treatment with topical corticosteroids and emollients, as occurs with other treatments for scabies.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Because the sample size (23 patients) was small for such a common disease, further research is advisable in order to confirm the findings of the study. We therefore suggest that the authors continue working in this direction.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Blasco Morente G. Ivermectina oral: recuperando un fármaco para el tratamiento de la escabiosis. Actas Dermosifiliogr. 2017;108:606.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "Reference" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:1 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:3 [ "comentario" => "pii: S0001-7310(17)30131-X. [Article in English, Spanish]" "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of Human Scabies with Oral Ivermectin. Eczematous Eruptions as a New Non-Reported Adverse Event" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J. Sanz-Navarro" 1 => "C. Feal" 2 => "E. Dauden" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2017.02.011" "Revista" => array:2 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2017" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010800000007/v2_201708291348/S1578219017301853/v2_201708291348/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000007/v2_201708291348/S1578219017301853/v2_201708291348/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301853?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 34 | 12 | 46 |
2024 Octubre | 251 | 41 | 292 |
2024 Septiembre | 239 | 24 | 263 |
2024 Agosto | 267 | 68 | 335 |
2024 Julio | 183 | 25 | 208 |
2024 Junio | 153 | 30 | 183 |
2024 Mayo | 134 | 30 | 164 |
2024 Abril | 145 | 21 | 166 |
2024 Marzo | 115 | 29 | 144 |
2024 Febrero | 95 | 30 | 125 |
2024 Enero | 90 | 27 | 117 |
2023 Diciembre | 66 | 19 | 85 |
2023 Noviembre | 77 | 32 | 109 |
2023 Octubre | 83 | 21 | 104 |
2023 Septiembre | 61 | 26 | 87 |
2023 Agosto | 35 | 10 | 45 |
2023 Julio | 62 | 31 | 93 |
2023 Junio | 59 | 22 | 81 |
2023 Mayo | 49 | 16 | 65 |
2023 Abril | 48 | 22 | 70 |
2023 Marzo | 52 | 21 | 73 |
2023 Febrero | 51 | 25 | 76 |
2023 Enero | 43 | 33 | 76 |
2022 Diciembre | 44 | 40 | 84 |
2022 Noviembre | 22 | 26 | 48 |
2022 Octubre | 25 | 17 | 42 |
2022 Septiembre | 20 | 34 | 54 |
2022 Agosto | 26 | 37 | 63 |
2022 Julio | 20 | 35 | 55 |
2022 Junio | 25 | 24 | 49 |
2022 Mayo | 77 | 47 | 124 |
2022 Abril | 81 | 26 | 107 |
2022 Marzo | 92 | 48 | 140 |
2022 Febrero | 104 | 19 | 123 |
2022 Enero | 174 | 46 | 220 |
2021 Diciembre | 98 | 49 | 147 |
2021 Noviembre | 126 | 46 | 172 |
2021 Octubre | 99 | 63 | 162 |
2021 Septiembre | 118 | 46 | 164 |
2021 Agosto | 101 | 39 | 140 |
2021 Julio | 43 | 35 | 78 |
2021 Junio | 53 | 42 | 95 |
2021 Mayo | 46 | 46 | 92 |
2021 Abril | 114 | 74 | 188 |
2021 Marzo | 73 | 44 | 117 |
2021 Febrero | 65 | 53 | 118 |
2021 Enero | 45 | 38 | 83 |
2020 Diciembre | 42 | 34 | 76 |
2020 Noviembre | 34 | 32 | 66 |
2020 Octubre | 32 | 24 | 56 |
2020 Septiembre | 37 | 22 | 59 |
2020 Agosto | 39 | 26 | 65 |
2020 Julio | 41 | 31 | 72 |
2020 Junio | 37 | 40 | 77 |
2020 Mayo | 24 | 16 | 40 |
2020 Abril | 29 | 12 | 41 |
2020 Marzo | 23 | 15 | 38 |
2020 Febrero | 5 | 0 | 5 |
2020 Enero | 2 | 0 | 2 |
2019 Diciembre | 4 | 0 | 4 |
2019 Noviembre | 4 | 0 | 4 |
2019 Septiembre | 4 | 0 | 4 |
2019 Agosto | 2 | 0 | 2 |
2019 Julio | 6 | 0 | 6 |
2019 Junio | 4 | 0 | 4 |
2019 Mayo | 4 | 0 | 4 |
2019 Abril | 2 | 0 | 2 |
2019 Febrero | 4 | 0 | 4 |
2019 Enero | 2 | 0 | 2 |
2018 Diciembre | 3 | 0 | 3 |
2018 Noviembre | 2 | 0 | 2 |
2018 Octubre | 2 | 0 | 2 |
2018 Septiembre | 3 | 0 | 3 |
2018 Febrero | 13 | 9 | 22 |
2018 Enero | 38 | 8 | 46 |
2017 Diciembre | 43 | 11 | 54 |
2017 Noviembre | 27 | 16 | 43 |
2017 Octubre | 25 | 21 | 46 |
2017 Septiembre | 81 | 34 | 115 |
2017 Agosto | 137 | 45 | 182 |
2017 Julio | 5 | 14 | 19 |